These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4129954)

  • 21. Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man.
    Levy G; O'Reilly RA; Wingard LB
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):359-65. PubMed ID: 4594366
    [No Abstract]   [Full Text] [Related]  

  • 22. An autoradiographic study of the distribution and excretion of 14C-dicoumarol in the rat.
    Maines MD; Wosilait WD
    Comp Gen Pharmacol; 1971 Jun; 2(6):184-8. PubMed ID: 4125708
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioavailability of dicumarol from different commercial tablets in dogs.
    Akers MJ; Lach JL; Fischer LJ
    J Pharm Sci; 1973 Jul; 62(7):1192-3. PubMed ID: 4123474
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of phenobarbital on bishydroxycoumarin plasma concentrations and hypoprothrombinemic responses in sheep.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 Apr; 33(4):825-34. PubMed ID: 4111741
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic control of dicumarol levels in man.
    Vesell ES; Page JG
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics of coumarin anticoagulants. 3. Factors affecting the distribution and elimination of bishydroxycoumarin (BHC) in isolated liver perfusion studies.
    Nagashima R; Levy G; Sarcione EJ
    J Pharm Sci; 1968 Nov; 57(11):1881-8. PubMed ID: 4177835
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of the anticoagulant effect of bishydroxycoumarin in man.
    O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1970; 11(3):378-84. PubMed ID: 4192280
    [No Abstract]   [Full Text] [Related]  

  • 28. The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone.
    Schrogie JJ; Solomon HM
    Clin Pharmacol Ther; 1967; 8(1):70-7. PubMed ID: 4163172
    [No Abstract]   [Full Text] [Related]  

  • 29. The anticoagulant response to bishydroxycoumarin. I. The role of individual variation.
    Solomon HM; Schrogie JJ
    Clin Pharmacol Ther; 1967; 8(1):65-9. PubMed ID: 4163171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Basic principles anticoagulant therapy].
    Mammen EF
    Internist (Berl); 1969 Jan; 10(1):2-8. PubMed ID: 4190310
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of diphenylhydantoin on the metabolism of dicoumarol in man.
    Hansen JM; Siersbaek-Nielsen K; Kristensen M; Skovsted L; Christensen LK
    Acta Med Scand; 1971; 189(1-2):15-9. PubMed ID: 4107730
    [No Abstract]   [Full Text] [Related]  

  • 32. Hazards of anticoagulant treatment: other drugs, other diseases.
    O'Reilly RA
    Thromb Diath Haemorrh Suppl; 1973; 56():211-7. PubMed ID: 4142116
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of coumarin anticoagulants XXXIII: frequency distribution of dicumarol total clearance in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Mar; 67(3):337-40. PubMed ID: 76673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the biliary excretion of 14C-dicumarol in the rat.
    Husain S; Eisenbrandt LL; Wosilait WD
    Drug Metab Dispos; 1973; 1(2):523-9. PubMed ID: 4132217
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling.
    Levy G; Lai CM; Yacobi A
    J Pharm Sci; 1978 Feb; 67(2):229-31. PubMed ID: 74408
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of drug metabolism in man.
    Vesell ES; Passananti GT
    Drug Metab Dispos; 1973; 1(1):402-10. PubMed ID: 4129869
    [No Abstract]   [Full Text] [Related]  

  • 37. The relationship between the dose of warfarin, free drug in plasma, and its elimination in the bile of rats.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):943-50. PubMed ID: 4760900
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative pharmacokinetics of coumarin anticoagulants XXXI: Effect of plasma protein binding on distribution kinetics of dicumarol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1741-3. PubMed ID: 72819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of anticoagulants by isolated rat hepatocytes.
    Wosilait WD; Ryan MP; Byington KH
    Drug Metab Dispos; 1981; 9(2):80-4. PubMed ID: 6165537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of some anticoagulant agents on coronary blood flow].
    Banaszkiewicz W; Kubacki A; Mrozikiewicz A
    Acta Physiol Pol; 1965; 16(6):917-21. PubMed ID: 4161745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.